Effect of selenium supplementation in treatment of patients candidate for coronary artery bypass grafting

Phase 3

• Conditions: Chronic ischaemic heart disease, unspecified; Coronary Heart Disease.; I25.9

• Registration Number: IRCT2017090533941N22
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients candidate for coronary artery bypass grafting

Exclusion Criteria

Consuming selenium supplements within the last 3 months
Having cardiac surgery within the past 3 months
Significant renal of hepatic failure
Change in the dosage and kind of medications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: At the beginning of the study and after 4 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Insulin. Timepoint: At the beginning of the study and after 4 weeks of intervention. Method of measurement: Elisa kit.